title: The European EUCCLID pilot study on care and complications in an unselected sample of people with type 2 diabetes in primary care.
abstract: BACKGROUND
  European studies on quality of diabetes care in an unselected primary care diabetes population are scarce.
  
  
  OBJECTIVE
  To test the feasibility of the set-up and logistics of a cross-sectional EUropean study on Care and Complications in patients with type 2 diabetes (T2DM) in Primary Care (EUCCLID) in 12 European countries.
  
  
  METHODS
  One rural and one urban practice from each country participated. The central coordinating centre randomly selected five patients from each practice. Patient characteristics were assessed including medical history, anthropometric measures, quality indicators, UKPDS-risk engine, psychological and general well-being.
  
  
  RESULTS
  We included 103 participants from 22 GPs in 11 countries. Central data and laboratory samples were successfully collected. Of the participants 54% were female, mean age was 66 years and mean duration of diabetes was 9.6 years. Besides, 18% were using insulin, 31% had a history of cardiovascular disease, mean HbA1c was 7.1% (range 6.6-8.0), mean systolic blood pressure was 133.7 mmHg (range 126.1-144.4) and mean total cholesterol was 4.9 mmol/l (range 4.0-6.2).
  
  
  CONCLUSIONS
  A European study on care and complications in a random selection of people with T2DM is feasible. There are large differences in indicators of metabolic control and wellbeing between countries.
authors.affiliation: Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, 3508 GA Utrecht, The Netherlands. K.J.Gorter@umcutrecht.nl
authors.forename: Kees J
authors.initials: KJ
authors.lastname: Gorter
authors.forename: Johan
authors.initials: J
authors.lastname: Wens
authors.forename: Kamlesh
authors.initials: K
authors.lastname: Khunti
authors.forename: Xavier Cos
authors.initials: XC
authors.lastname: Claramunt
authors.forename: Pinar
authors.initials: P
authors.lastname: Topsever
authors.forename: Thomas
authors.initials: T
authors.lastname: Drivsholm
authors.forename: Anne Karen
authors.initials: AK
authors.lastname: Jenum
authors.forename: Christophe
authors.initials: C
authors.lastname: Berkhout
authors.forename: Mykola
authors.initials: M
authors.lastname: Khalangot
authors.forename: Margalit
authors.initials: M
authors.lastname: Goldfracht
authors.forename: Imre
authors.initials: I
authors.lastname: Rurik
authors.forename: Christos
authors.initials: C
authors.lastname: Lionis
authors.forename: Guy E H M
authors.initials: GE
authors.lastname: Rutten
mesh_terms: D000368:Aged; D003430:Cross-Sectional Studies; D003924:Diabetes Mellitus, Type 2 / Q000150:complications* / Q000628:therapy*; D005060:Europe; D005260:Female; D006801:Humans; D007557:Israel; D008297:Male; D008875:Middle Aged; D015337:Multicenter Studies as Topic; D010865:Pilot Projects; D011320:Primary Health Care / Q000592:standards*; D016896:Treatment Outcome